Cowen And Company, LLC Sarepta Therapeutics, Inc. Transaction History

Cowen And Company, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$67.31 - $124.76 $1.15 Million - $2.12 Million	17,012 New	17,012 $1.64 Million
Q2 2022 Aug 05, 2022	SELL	$62.69 - $88.44 $452,496 - $638,359	-7,218 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $401,381 - $574,709	6,356 Added 737.35%	7,218 $564,000
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $853,093 - $1.1 Million	-11,039 Reduced 92.76%	862 $78,000
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $785,108 - $1.1 Million	11,901 New	11,901 $1.1 Million
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $333,777 - $616,231	-3,589 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$82.38 - $131.64 $36,576 - $58,448	444 Added 14.12%	3,589 $351,000
Q4 2019 Feb 11, 2020	BUY	$76.53 - $135.58 $240,686 - $426,399	3,145 New	3,145 $406,000

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.